Entity Public Float in USD of Calidi Biotherapeutics, Inc. from Q3 2021 to Q2 2024

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
Calidi Biotherapeutics, Inc. quarterly Entity Public Float history and change rate from Q3 2021 to Q2 2024.
  • Calidi Biotherapeutics, Inc. Entity Public Float for the quarter ending 28 Jun 2024 was $14M, a 67.6% decline year-over-year.
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

Calidi Biotherapeutics, Inc. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $14M -$29.3M -67.6% 28 Jun 2024 10-K 31 Mar 2025
Q2 2023 $43.3M -$185M -81.1% 30 Jun 2023 10-K 15 Mar 2024
Q2 2022 $229M 30 Jun 2022 10-K 31 Mar 2023
Q3 2021 $226M 10 Sep 2021 10-K 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.